SA
PRGTX logo
T. Rowe Price Global Technology Fund(PRGTX)
Last print 8 days agoAbout this dataData status
$29.69▲0.16 (0.54%)Stale · 8 days old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.6 · elevated volatility

Overview →

T. Rowe Price Global Technology Fund (PRGTX)

Total Current Assets

$30.45B

Quarterly · Period ending: · USD

PRGTX logo

PRGTX Total Current Assets

Latest reported$36.46B
PRGTX FY Current Assets ($22.71B → $36.46B)
High-resolution chart · PNG

What is total current assets?

Assets expected to be converted to cash within one year.

PRGTX total current assets history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

T. Rowe Price Global Technology Fund Total Current Assets — Annual fiscal periods (USD)
Period endingTotal Current Assets (USD)
36,458,000,000
33,108,000,000
170,768,000,000
52,008,000,000
54,761,000,000
51,427,000,000
79,146,000,000
38,369,000,000
35,992,000,000
33,606,000,000
23,196,000,000
22,706,000,000

Frequently asked questions: PRGTX total current assets

What is T. Rowe Price Global Technology Fund (PRGTX)'s current total current assets?

T. Rowe Price Global Technology Fund (PRGTX)'s latest reported total current assets (Quarterly) is $30.45B as of Mar 31, 2024. Assets expected to be converted to cash within one year.

How much historical total current assets data is available for PRGTX?

Stock Alarm Pro provides 12 dated annual fiscal periods observations for T. Rowe Price Global Technology Fund (PRGTX)'s total current assets, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PRGTX's total current assets to peers or set an alert?

You can open PRGTX's total current assets in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PRGTX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.